All research
2026-07-05 PubMed

IgA Nephropathy with Minimal Change Disease Can Cause Severe Acute Kidney Injury Requiring Hemodialysis

Immunoglobulin A nephropathy with superimposed minimal change disease complicated by acute kidney injury requiring temporary hemodialysis.

Background

Primary IgA nephropathy (IgAN) is the most common glomerulonephritis globally and a leading cause of end-stage kidney disease. It's characterized by mesangial IgA deposition, often triggering complement activation. Minimal change disease (MCD) is a distinct cause of nephrotic syndrome, marked by podocyte foot process effacement. The co-occurrence of IgAN with superimposed MCD is rare but increasingly recognized, typically associated with a favorable renal prognosis. However, the potential for severe complications in this combined phenotype remains a critical area for clinical understanding.

Study Design

This case report details a 38-year-old man presenting with acute nephrotic syndrome. A renal biopsy was performed, revealing mesangial IgA deposition. Anti-galactose-deficient IgA1 antibody (KM55) staining confirmed co-localization with IgA deposits, supporting the diagnosis of IgAN with superimposed MCD. Electron microscopy further identified characteristic foot process effacement. Initial treatment involved high-dose prednisolone therapy. Following the development of severe acute kidney injury (AKI), concurrent treatment with cyclosporine A and steroid pulse therapy was administered to manage the renal crisis.

Results

The patient's renal biopsy confirmed IgAN with MCD, evidenced by mesangial IgA deposition and KM55 staining co-localization. Electron microscopy definitively showed foot process effacement. Despite initial high-dose prednisolone treatment, the patient's condition deteriorated, leading to severe acute kidney injury (AKI) that necessitated temporary hemodialysis (HD). This severe complication occurred despite the generally favorable prognosis associated with IgAN with MCD. > The patient ultimately responded to concurrent cyclosporine A and steroid pulse therapy, allowing for successful discontinuation of HD and subsequent improvements in renal function and proteinuria. This demonstrates that severe AKI requiring temporary HD can occur in IgAN with MCD, but may be reversible.

Key Findings

  • A 38-year-old man developed severe acute kidney injury (AKI) requiring temporary hemodialysis.
  • Diagnosis was confirmed as IgA nephropathy with superimposed minimal change disease via renal biopsy and KM55 staining.
  • Electron microscopy revealed characteristic foot process effacement.
  • Aggressive treatment with cyclosporine A and steroid pulse therapy allowed successful discontinuation of hemodialysis.
  • Renal function and proteinuria subsequently improved, suggesting reversibility of severe AKI in this context.

Why It Matters

This case underscores a critical, albeit rare, clinical scenario: IgA nephropathy with minimal change disease can lead to severe acute kidney injury requiring hemodialysis. Despite the typically favorable prognosis of this combined condition, clinicians must maintain a high index of suspicion for AKI. The successful discontinuation of hemodialysis and subsequent renal recovery with aggressive immunosuppressive therapy (cyclosporine A and steroid pulse therapy) suggests that this severe complication may be reversible. This highlights the importance of careful monitoring and prompt, intensive management to preserve renal function in these patients, potentially altering the long-term outlook for those who develop severe AKI.


iga nephropathy minimal change disease acute kidney injury nephrotic syndrome case report kidney disease
Source: pubmed:42400865 · Ingested 2026-07-05 · Digest: gemini-2.5-flash